IRMD
What one share of Iradimed holds
Surgical and Medical Instruments and Apparatus
IRADIMED CORPORATION (“IRadimed”, the “Company,” “we,” “us,” “our” or similar terms) develops, manufactures, markets and distributes Magnetic Resonance Imaging (“MRI”) compatible medical devices and related accessories, disposables and services relating to them.
Iradimed’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $6.71 |
|---|---|
| Profit | $1.79 |
| Capex (buildings and equipment) | $0.16 |
| Free cash flow | $1.95 |
| Dividends | $1.23 |
| Cash and investments | $4.62 |
| Book value | $7.96 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $2.71 | $0.60 | $0.07 | $0.72 | — | $2.97 |
| 2017 | $1.97 | $0.04 | $0.07 | $0.23 | — | $3.11 |
| 2018 | $2.51 | $0.52 | $0.02 | $0.59 | — | $3.82 |
| 2019 | $3.14 | $0.78 | $0.03 | $0.80 | — | $4.72 |
| 2020 | $2.55 | $0.11 | $0.04 | $0.43 | — | $4.99 |
| 2021 | $3.32 | $0.74 | $0.04 | $0.86 | — | $5.75 |
| 2022 | $4.22 | $1.02 | $0.07 | $0.73 | — | $5.85 |
| 2023 | $5.15 | $1.35 | $0.58 | $0.47 | — | $5.64 |
| 2024 | $5.73 | $1.50 | $0.63 | $1.38 | — | $6.83 |
| 2025 | $6.52 | $1.75 | $0.60 | $1.34 | — | $7.40 |